Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Document Details

Form

Filing Date

Jul 27, 2023

Document Date

Jul 25, 2023

Form Description

Report of unscheduled material events or corporate event

Filing Group

Current Reports

Company

Homology Medicines, Inc.

Issuer

Homology Medicines, Inc.

Filing Formats

iXBRL

View HTML

XBRL

XBRL Viewer

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE

EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

XML - XBRL INSTANCE DOCUMENT

MENU